nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.153	0.215	CbGbCtD
Clofazimine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.104	0.145	CbGbCtD
Clofazimine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0989	0.139	CbGbCtD
Clofazimine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0881	0.124	CbGbCtD
Clofazimine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0863	0.121	CbGbCtD
Clofazimine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0815	0.114	CbGbCtD
Clofazimine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0517	0.0726	CbGbCtD
Clofazimine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0488	0.0685	CbGbCtD
Clofazimine—Completed suicide—Roflumilast—chronic obstructive pulmonary disease	0.0121	0.042	CcSEcCtD
Clofazimine—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.00981	0.0341	CcSEcCtD
Clofazimine—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00705	0.0245	CcSEcCtD
Clofazimine—Suicide—Montelukast—chronic obstructive pulmonary disease	0.00681	0.0237	CcSEcCtD
Clofazimine—Intestinal obstruction—Tiotropium—chronic obstructive pulmonary disease	0.00656	0.0228	CcSEcCtD
Clofazimine—Thromboembolism—Prednisolone—chronic obstructive pulmonary disease	0.00614	0.0214	CcSEcCtD
Clofazimine—Completed suicide—Montelukast—chronic obstructive pulmonary disease	0.00601	0.0209	CcSEcCtD
Clofazimine—Acneiform eruption—Prednisone—chronic obstructive pulmonary disease	0.00562	0.0195	CcSEcCtD
Clofazimine—Bone pain—Tiotropium—chronic obstructive pulmonary disease	0.00467	0.0162	CcSEcCtD
Clofazimine—Thromboembolism—Prednisone—chronic obstructive pulmonary disease	0.00446	0.0155	CcSEcCtD
Clofazimine—Dermatitis acneiform—Prednisone—chronic obstructive pulmonary disease	0.00415	0.0144	CcSEcCtD
Clofazimine—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00403	0.014	CcSEcCtD
Clofazimine—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00399	0.0139	CcSEcCtD
Clofazimine—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00399	0.0139	CcSEcCtD
Clofazimine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00396	0.0138	CcSEcCtD
Clofazimine—Embolism venous—Prednisolone—chronic obstructive pulmonary disease	0.00387	0.0135	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00365	0.0127	CcSEcCtD
Clofazimine—Cystitis noninfective—Arformoterol—chronic obstructive pulmonary disease	0.00352	0.0122	CcSEcCtD
Clofazimine—Cystitis noninfective—Formoterol—chronic obstructive pulmonary disease	0.00352	0.0122	CcSEcCtD
Clofazimine—Cystitis—Formoterol—chronic obstructive pulmonary disease	0.00348	0.0121	CcSEcCtD
Clofazimine—Cystitis—Arformoterol—chronic obstructive pulmonary disease	0.00348	0.0121	CcSEcCtD
Clofazimine—Bladder pain—Arformoterol—chronic obstructive pulmonary disease	0.00326	0.0113	CcSEcCtD
Clofazimine—Bladder pain—Formoterol—chronic obstructive pulmonary disease	0.00326	0.0113	CcSEcCtD
Clofazimine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00314	0.0109	CcSEcCtD
Clofazimine—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00313	0.0109	CcSEcCtD
Clofazimine—Embolism—Prednisolone—chronic obstructive pulmonary disease	0.00304	0.0106	CcSEcCtD
Clofazimine—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.0101	CcSEcCtD
Clofazimine—Embolism venous—Prednisone—chronic obstructive pulmonary disease	0.00281	0.00978	CcSEcCtD
Clofazimine—Hepatomegaly—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.00959	CcSEcCtD
Clofazimine—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00932	CcSEcCtD
Clofazimine—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.00879	CcSEcCtD
Clofazimine—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00828	CcSEcCtD
Clofazimine—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00828	CcSEcCtD
Clofazimine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.00785	CcSEcCtD
Clofazimine—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00782	CcSEcCtD
Clofazimine—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00221	0.00769	CcSEcCtD
Clofazimine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.0022	0.00766	CcSEcCtD
Clofazimine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00763	CcSEcCtD
Clofazimine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00219	0.0076	CcSEcCtD
Clofazimine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00217	0.00754	CcSEcCtD
Clofazimine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00216	0.00752	CcSEcCtD
Clofazimine—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00709	CcSEcCtD
Clofazimine—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00709	CcSEcCtD
Clofazimine—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.00201	0.00697	CcSEcCtD
Clofazimine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00687	CcSEcCtD
Clofazimine—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.0067	CcSEcCtD
Clofazimine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00193	0.0067	CcSEcCtD
Clofazimine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00662	CcSEcCtD
Clofazimine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00645	CcSEcCtD
Clofazimine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00632	CcSEcCtD
Clofazimine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00617	CcSEcCtD
Clofazimine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00607	CcSEcCtD
Clofazimine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00607	CcSEcCtD
Clofazimine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.00603	CcSEcCtD
Clofazimine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00168	0.00583	CcSEcCtD
Clofazimine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.0056	CcSEcCtD
Clofazimine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.0056	CcSEcCtD
Clofazimine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.00556	CcSEcCtD
Clofazimine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.00555	CcSEcCtD
Clofazimine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00554	CcSEcCtD
Clofazimine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.00552	CcSEcCtD
Clofazimine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00151	0.00523	CcSEcCtD
Clofazimine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.00511	CcSEcCtD
Clofazimine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00474	CcSEcCtD
Clofazimine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00465	CcSEcCtD
Clofazimine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00447	CcSEcCtD
Clofazimine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00447	CcSEcCtD
Clofazimine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00438	CcSEcCtD
Clofazimine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00422	CcSEcCtD
Clofazimine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00416	CcSEcCtD
Clofazimine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00403	CcSEcCtD
Clofazimine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00402	CcSEcCtD
Clofazimine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00398	CcSEcCtD
Clofazimine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00398	CcSEcCtD
Clofazimine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00392	CcSEcCtD
Clofazimine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00389	CcSEcCtD
Clofazimine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00389	CcSEcCtD
Clofazimine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00386	CcSEcCtD
Clofazimine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00386	CcSEcCtD
Clofazimine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00382	CcSEcCtD
Clofazimine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00382	CcSEcCtD
Clofazimine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00378	CcSEcCtD
Clofazimine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00375	CcSEcCtD
Clofazimine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00374	CcSEcCtD
Clofazimine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00371	CcSEcCtD
Clofazimine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.0037	CcSEcCtD
Clofazimine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00368	CcSEcCtD
Clofazimine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00367	CcSEcCtD
Clofazimine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00366	CcSEcCtD
Clofazimine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00364	CcSEcCtD
Clofazimine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00361	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00358	CcSEcCtD
Clofazimine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00354	CcSEcCtD
Clofazimine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00354	CcSEcCtD
Clofazimine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00352	CcSEcCtD
Clofazimine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00349	CcSEcCtD
Clofazimine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00349	CcSEcCtD
Clofazimine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00349	CcSEcCtD
Clofazimine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000999	0.00347	CcSEcCtD
Clofazimine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000996	0.00346	CcSEcCtD
Clofazimine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00334	CcSEcCtD
Clofazimine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000947	0.00329	CcSEcCtD
Clofazimine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000945	0.00329	CcSEcCtD
Clofazimine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000938	0.00326	CcSEcCtD
Clofazimine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00321	CcSEcCtD
Clofazimine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00321	CcSEcCtD
Clofazimine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00091	0.00316	CcSEcCtD
Clofazimine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00091	0.00316	CcSEcCtD
Clofazimine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000904	0.00314	CcSEcCtD
Clofazimine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000892	0.0031	CcSEcCtD
Clofazimine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00088	0.00306	CcSEcCtD
Clofazimine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00088	0.00306	CcSEcCtD
Clofazimine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00303	CcSEcCtD
Clofazimine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000862	0.003	CcSEcCtD
Clofazimine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00299	CcSEcCtD
Clofazimine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000851	0.00296	CcSEcCtD
Clofazimine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000851	0.00296	CcSEcCtD
Clofazimine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000833	0.0029	CcSEcCtD
Clofazimine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.00289	CcSEcCtD
Clofazimine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000818	0.00284	CcSEcCtD
Clofazimine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000818	0.00284	CcSEcCtD
Clofazimine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000811	0.00282	CcSEcCtD
Clofazimine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000811	0.00282	CcSEcCtD
Clofazimine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000811	0.00282	CcSEcCtD
Clofazimine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000811	0.00282	CcSEcCtD
Clofazimine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000806	0.0028	CcSEcCtD
Clofazimine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000806	0.0028	CcSEcCtD
Clofazimine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000806	0.0028	CcSEcCtD
Clofazimine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00279	CcSEcCtD
Clofazimine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000803	0.00279	CcSEcCtD
Clofazimine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00279	CcSEcCtD
Clofazimine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000795	0.00276	CcSEcCtD
Clofazimine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000794	0.00276	CcSEcCtD
Clofazimine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000792	0.00275	CcSEcCtD
Clofazimine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00079	0.00274	CcSEcCtD
Clofazimine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000773	0.00269	CcSEcCtD
Clofazimine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000766	0.00266	CcSEcCtD
Clofazimine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000765	0.00266	CcSEcCtD
Clofazimine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00266	CcSEcCtD
Clofazimine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00266	CcSEcCtD
Clofazimine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000761	0.00265	CcSEcCtD
Clofazimine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000749	0.0026	CcSEcCtD
Clofazimine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00251	CcSEcCtD
Clofazimine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000697	0.00242	CcSEcCtD
Clofazimine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000573	0.00199	CcSEcCtD
Clofazimine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000506	0.00176	CcSEcCtD
Clofazimine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000483	0.00168	CcSEcCtD
Clofazimine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.0016	CcSEcCtD
Clofazimine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00044	0.00153	CcSEcCtD
Clofazimine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000439	0.00153	CcSEcCtD
Clofazimine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000439	0.00153	CcSEcCtD
Clofazimine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00152	CcSEcCtD
Clofazimine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000437	0.00152	CcSEcCtD
Clofazimine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00151	CcSEcCtD
Clofazimine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00144	CcSEcCtD
Clofazimine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00139	CcSEcCtD
Clofazimine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00126	CcSEcCtD
Clofazimine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00125	CcSEcCtD
Clofazimine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000346	0.0012	CcSEcCtD
Clofazimine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00116	CcSEcCtD
Clofazimine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000322	0.00112	CcSEcCtD
Clofazimine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00111	CcSEcCtD
Clofazimine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00111	CcSEcCtD
Clofazimine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000317	0.0011	CcSEcCtD
Clofazimine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00105	CcSEcCtD
